Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring
El Missiri, Ahmed; Rayan, Mona Mostafa; Awad, Mohamed Medhat; El Desoky, Ahmed Ibrahim;
Abstract
Direct-acting antiviral agents (DAAs) cure patients with hepatitis C virus (HCV) infection. Concerns have arisen the occurrence of significant bradyarrhythmias during treatment with DAAs. The aim of this study was to assess the impact of a DAA combination for the treatment of HCV infection on heart rate, rhythm, and heart rate variability (HRV) using 24-h ECG monitoring.
Other data
| Title | Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring | Authors | El Missiri, Ahmed ; Rayan, Mona Mostafa; Awad, Mohamed Medhat; El Desoky, Ahmed Ibrahim | Keywords | Bradycardia;Sofosbuvir;Holter;ECG monitoring;Daclatasvir | Issue Date | 1-Jul-2020 | Journal | The Egyptian Heart Journal | Volume | 72 | Issue | 37 | ISSN | 2090-911X | DOI | 10.1186/s43044-020-00070-4 | PubMed ID | 32613565 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.